中纪委明确严打医疗行业收受回扣等乱象

Core Viewpoint - The article emphasizes the importance of anti-corruption efforts in the healthcare sector to protect public health and ensure the integrity of the industry, with a focus on the management of medical insurance funds as a critical area for oversight [1][2]. Group 1: Anti-Corruption Efforts - In 2025, the Chinese government intensified its anti-corruption measures in the healthcare sector, particularly in the management of medical insurance funds, as part of a broader strategy to safeguard public interests [1][4]. - The Central Commission for Discipline Inspection and the National Supervisory Commission highlighted the need for strict enforcement against fraudulent activities related to medical insurance, including collusion and illegal fund extraction [1][5]. - The anti-corruption campaign is expected to deepen in 2026, focusing on high-risk areas such as drug procurement and medical equipment, while targeting key personnel involved in these processes [8][9]. Group 2: Medical Insurance Fund Management - The management of medical insurance funds is crucial for maintaining social stability and addressing public health concerns, with the government recovering approximately 120 billion yuan (around 18.5 billion USD) in fraudulent claims over the past five years [4]. - Innovative measures, such as the implementation of drug traceability codes, have been introduced to combat illegal practices like the resale of drugs, with over 100 billion traceability codes collected [4][5]. - Local governments have actively participated in the oversight of medical insurance funds, with various regions reporting significant recoveries of misused funds, such as 215 million yuan (approximately 32.5 million USD) in Suixi County [5][6]. Group 3: Regulatory Measures and Technology - The article outlines specific regulatory measures for 2026, including increased flying inspections across all regions and targeted checks on areas with high patient out-of-pocket expenses [6][8]. - The use of technology, such as data models for identifying fraudulent activities, is emphasized as a key component in enhancing the efficiency of medical insurance fund supervision [5][11]. - The establishment of transparent procurement processes for medical equipment aims to reduce corruption risks by consolidating purchasing activities and ensuring public oversight [11][12].